A significant (*p < 0.05) decrease in TBARS levels of aliskiren-treated group (3) in comparison to the cholesterol-fed non-treated group (2). • * p<0.05= significant increase in TBARS levels in group (2) compared to the control group (1) • ** p<0.05 = significant decrease in TBARS levels in cholesterol-fed aliskirentreated group (3) compared to the cholesterol-fed non-treated rats group (2)

Figure 2: Effect of 12 weeks administration of aliskiren to cholesterol-fed rats on thiobarbituric acid reactive substance (TBARS) in nmol/mg tissue protein of the aortic tissue homogenates of rats of all tested groups.